Clinical Trial Update: Study to Evaluate the Efficacy of GS-9131 Functional Monotherapy in Human Immunodeficiency Virus (HIV)-1-Infected Adults Failing a Nucleos(t)Ide Reverse Transcriptase Inhibitor-Containing Regimen With Nucleos(t)Ide Reverse Transcriptase Inhibitor Resistant Virus [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating GS-9131 monotherapy in HIV-1-infected adults failing a NRTI-containing regimen with NRTI-resistant virus; study terminated with results…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• HIV Infection

Drugs mentioned

• GS-9131

Snippet

Sponsor: Gilead Sciences | Conditions: HIV-1-infection | Phase 2 | Status: TERMINATED | Results posted: 2021-01-05